https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-voluntary-pause-elevidys
0
0
7/21/25 at 11:40pm
Organization
Sarepta.com
51 words
0
Comments
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jul. 21, 2025-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: Today, Sarepta Therapeutics notified the U.S. Food and Drug Adminis…
You are the first to view
Create an account
or login to join the discussion